Autoimmune hepatitis (AIH) is a severe and chronic progressive inflammatory liver ailment characterized by an enduring autoimmune response directed against liver autoantigens [ 1 , 2 ]. Primary cholestatic hepatitis (PBC) manifests as a chronic …

Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease characterized by progressive nonsuppurative cholangitis [ 1 ]. Without pharmacological interventions, patients can progress to liver cirrhosis and hepatocellular carcinoma.

Primary Biliary Cholangitis (PBC) is a chronic cholestatic liver disease involving the autoimmune-mediated destruction of biliary epithelial cells. PBC is a progressive disorder, and may ultimately result in hepatic fibrosis, cirrhosis, and …

Primary biliary cholangitis (PBC) is a chronic inflammatory autoimmune-mediated liver disease that is characterized by primary progressive destruction of the small intrahepatic bile ducts, impaired biliary secretion, and hepatocellular retention …

Overlap syndrome is a condition characterized by the coexistence of features belonging to different disorders within the spectrum of autoimmune liver diseases: autoimmune hepatitis (AIH), primary biliary cholangitis (PBC), and primary sclerosing …

Primary biliary cholangitis (PBC) is an autoimmune liver disease characterized by inflammation of the interlobular bile ducts and interstitial bile duct cells. The natural course of disease tends to be progressive. In the absence of proper …

Primary biliary cholangitis (PBC) is a chronic idiopathic disorder, characterized by bile accumulation and progressive necrosis of the intrahepatic bile ducts. Unlike primary sclerosing cholangitis (PSC), which is characterized by fibrotic changes …

Primary biliary cholangitis (PBC) is a slowly progressive disease with a natural course of 10–15 years, but high-risk patients can progress rapidly to decompensated cirrhosis and even death [ 1 ]. Early identification of such patients and timely …

Primary biliary cholangitis (PBC) is an autoimmune-mediated intrahepatic cholestatic disease characterised by progressive, nonsuppurative, destructive intrahepatic cholangitis, leading to hepatic fibrosis and eventually cirrhosis and a range of …

The clinical and epidemiological characteristics of Vibrio vulnificus infection were first reported in 1979 by Blake et al . V. vulnificus is a slightly halophilic Gram-negative bacillus with an optimal salt concentration of 2–3% that lives in …

Primary biliary cholangitis (PBC) is a chronically progressive, cholestatic liver disease characterised by non-suppurative inflammation mediated by an autoimmune response [ 1 ]. It mostly occurs in middle-aged women [ 2 ]. The onset of PBC is …

Primary Biliary Cholangitis (PBC) is an uncommon cholestatic, chronic, autoimmune disease. The global incidence rate is between 0.33 and 0.58 per 100,000 inhabitants/year and the prevalence varies from 1.91 to 40.2 per 100,000 individuals [ 1 ]. In …

Primary biliary cholangitis (PBC) is a rare chronic autoimmune-mediated cholestatic liver disease involving medium and small bile ducts that can lead to liver fibrosis and cirrhosis. To date, the pathogenesis of PBC remains elusive, and there is …

Primary biliary cholangitis (PBC, formerly known as primary biliary cirrhosis) is a chronic and cholestatic autoimmune liver disease characterized by the destruction of intrahepatic small bile ducts, leading to inflammation, fibrosis, hepatic …

Primary biliary cholangitis (PBC) is an autoimmune liver disease, characterized by female predominance, non-suppurative destruction of small bile ducts, and specific anti-mitochondrial antibodies (AMAs) [ 1 , 2 ]. The etiology and pathogenesis of …